Lab Automation Market
Lab Automation Market: Research Institutes and Educational Institutions End Use Segments to Show Potential Growth in the Coming Years: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)
- 2017-10-31
- REP-GB-394
- 257 pages
-
An Incisive, In-depth Analysis on the Lab Automation Market
This study offers a comprehensive, 360 degree analysis on the Lab Automation market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Lab Automation market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
COVID -19 : Impact Analysis
Request the coronavirus imapact analysis across industries and markets
Request Covid -19 ImpactAn introduction to the lab automation market
Lab automation is the process of the integration of various types of devices on a same platform, such as diagnostic analyzers, research devices, and supportive instruments and software to increase throughput with remarkable speed, precise motion, and consistency in report generation. During the automation of a routine laboratory, dedicated workstations and software are used to program instruments, which allows scientists and technicians to maintain consistency in quality and result output by reducing mundane tasks. The growing number of diagnosed cases and increasing real-time result analysis with the advent of automation techniques have led to a threefold increase in the demand for automated devices, services, and advanced software.
Lab automation offerings consist of two types of components - devices and software. The devices section consists of biochemistry devices, molecular devices, hematology devices, immunology devices, microbiology devices, and others. In the software section, FMI has included scheduling software and momentum integrated software. In the overall lab automation market, the devices segment has the largest market share in terms of value, which has a huge potential in the coming future, due to the increasing demand for biochemistry devices and molecular devices.
Due to the dominant features and advantages, lab automation is preferred by the diagnostics industry, followed by drug discovery and research labs. Lab automation has a wide variety of applications in life sciences, ranging from clinical pathology to molecular research. In clinical diagnostics such as biochemistry, hematology, microbiology, and immunology, high throughput is directly proportional to time efficiency and operator safety. While research organizations and academic institutions generally prefer automation, which reduces human intervention in tedious and repetitive tasks. The global lab automation systems market was valued at US$ 1,130 Mn in 2016, and is expected to expand at a CAGR of 9.6% over the forecast period (2017–2027).
Increasing acceptance of lab automation in developing economies and rising use of lab automation in large integrated health systems to boost revenue growth
Emerging countries in the Asia Pacific region such as China and India are the major countries for investment opportunities because of higher growth rates of molecular-based diagnosis, quality improvisations, increasing number of partnerships, and healthcare modernization in these countries. To increase revenue share, medical device manufacturing companies are focusing on the development of automated devices used for in-vitro diagnosis and research, with advanced facilities, which will indirectly pump growth into the lab automation market, and also boost the software and services revenue over the forecast period. The increasing demand for high-end, advanced lab automation devices from end users, such as pharmaceutical and biotechnology companies, hospitals and diagnostics centers, ambulatory surgical centers, educational institutes, and research organizations for better output and performance will generate opportunities for the launching of novel lab automation techniques and services in the market over the long run.
The use of lab automation services has increased very steeply over the past decade. Lab automation services help in increasing throughput at a remarkable speed, and with precise motion and consistency in report generation. The growing number of diagnosis cases and real-time result analysis with the advent of automation techniques has led to a threefold increase in the demand for automated devices, and advanced software and services. The aforesaid factors will increase the demand for lab automation in large integrated healthcare systems.
Several players in the lab automation market are majorly focusing on new automated device launches and services to reduce the costs of lab automation services, in order to gain maximum market share. Acquisition, mergers, strategic collaborations, and technology play a vital role in the growth of the lab automation market.
The global lab automation market is categorized on the basis of product type, application, end user, and region
On the basis of component, the lab automation market is segmented by devices and software. Further, the devices segment has been segmented into six categories - biochemistry devices, molecular devices, hematology devices, immunology devices, microbiology devices, and others. The software segment is bifurcated into two segments scheduling software and momentum integration software.
On the basis of application, the lab automation market is segmented into life sciences research & development, drug-discovery, and diagnostics. In terms of revenue share, the life sciences R&D segment dominated the global lab automation market in 2017, and is expected to do so throughout the forecast period. The diagnostics application segment is anticipated to expand at the fastest CAGR over the forecast period.
On the basis of end user, the global lab automation market is segmented into pharmaceutical companies, hospitals and diagnostic centers, educational institutions, contract research organizations (CROs), and research institutes. The hospitals and diagnostic centers segment currently accounts for the highest revenue in the lab automation market, due to the increasing usage of automation devices in hospitals and diagnostic centers in developed countries.
North America and Western Europe are expected to maintain key market positions in the lab automation market in the coming years
Among the key regional markets, the North American lab automation market is projected to exhibit relatively higher growth in the global lab automation market, with a CAGR of over 10.7% during the forecast period. Revenue from the lab automation markets in North America and Western Europe are expected to collectively account for over 57.2% of the global lab automation market revenue in 2017. Key competitors in the lab automation market are Abbott Laboratories, Agilent Technologies, Perkin Elmer, Inc, Thermo Fisher Scientific, Inc, Siemens Healthcare, Danaher Corporation, Becton, Dickinson and Company, and Transcriptic, Inc.
Synopsis of the Lab Automation Market
Future Market Insights offers a 10-year forecast on the lab automation market between 2017 and 2027. In terms of value, the lab automation market is expected to register a CAGR of 9.6% during forecast period. This lab automation market study demonstrates the global market dynamics and trends across various regions such as North America, Latin America, Western Europe, Eastern Europe, APEJ, Middle East & Africa, and Japan, which influence the current nature and future status of the lab automation market over the forecast period.
Lab Automation Market: Report Description
This research report provides a detailed analysis of the lab automation market, and offers insights on various factors. This lab automation market study provides a comprehensive assessment of stakeholder strategies and imperatives for succeeding in the business. The stakeholders in this lab automation market include healthcare automation providers, hospitals, pharmacies, and clinics. The lab automation report segregates the market based on component: devices and software; application, and end users across different regions, worldwide.
The increasing demand for technically advanced automated lab devices and platforms in various verticals such as biochemistry, hematology, microbiology, immunology, and molecular biology, for improved and accurate diagnosis, is anticipated to drive the growth of the lab automation market over the forecast period. Advancements in lab automation allow process standardization, which, in turn, decreases the frequency of outliers and errors, and is a key factor expected to propel the growth of the lab automation market.
The report starts with an overview of the global lab automations market in terms of value. In addition, this section includes the analysis of key trends, drivers, and restraints that are influencing the lab automation market. An impact analysis of key growth drivers and restraints is included in the lab automations market report to facilitate clients with crystal-clear decision-making insights.
The global lab automation market is categorized on the basis of component, application, end user, and region. On the basis of component, the lab automation market is segmented into devices and software. Further, the devices segment has been segmented into six categories - biochemistry devices, molecular devices, hematology devices, immunology devices, microbiology devices, and others. The software segment is bifurcated into two segments scheduling software and momentum integration software.
On the basis of application, the lab automation market is segmented into life sciences research & development, drug-discovery, and diagnostics. In terms of revenue share, the life sciences R&D segment dominated the global lab automation market in 2017, and is expected to do so throughout the forecast period. The diagnostics application segment is anticipated to expand at the fastest CAGR over the forecast period.
On the basis of end user, the global lab automation market is segmented into pharmaceutical companies, hospitals and diagnostic centers, educational institutions, contract research organizations (CROs), and research institutes. The hospitals and diagnostic centers segment currently accounts for the highest revenue in the lab automation market, due to the increasing usage of automation devices in hospitals and diagnostic centers in developed countries.
The next section highlights a detailed analysis of the lab automation market across various countries in different regions. It provides a market outlook for 2017–2027, and sets the forecast within the context of the lab automation market to include the latest technological developments as well as service offerings in the market. This lab automation market study discusses key trends within countries contributing to the growth of the lab automation market, as well as analyses degrees at which the drivers are influencing this market in each region. Key regions and countries assessed in the lab automation report include North America (U.S. and Canada), Latin America (Brazil, Mexico, Argentina and the Rest of Latin America), Western Europe (Germany, UK, France, Italy, Spain, Nordic, and the Rest of Europe), Eastern Europe (Russia, Poland, and the Rest of Eastern Europe), APEJ (India, China, ASEAN, Australia and New Zealand, and the Rest of APEJ), Japan, and MEA (South Africa, GCC Countries, and Rest of MEA).
The report evaluates the present scenario and growth prospects of the lab automation market across various regions, globally, for the period 2017–2027. We have considered 2016 as the base year, and provided data for the remaining 12 months. The forecast presented in the lab automation market report assesses the total revenue by value across the market. To offer an accurate forecast, we started by sizing the current lab automation market, which forms the basis of how the lab automation market will develop in the future. Given the characteristics of the lab automation market, we have triangulated the outcome of the analysis of different types and verticals based on technology trends.
In addition, it is imperative to note that, in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse on the basis of key parameters such as Year-on-Year (Y-o-Y) growth, to understand the predictability of the lab automation market, and to identify the right opportunities across the market.
In the final section of the lab automation market report, we have included a competitive landscape to provide clients a dashboard view based on the categories of providers in the value chain, their presence in the lab automation portfolio, and key differentiators. This section is primarily designed to provide clients an objective and detailed comparative assessment of key providers specific to a market segment in the lab automation value chain, as well as the potential players for the same. Audiences of the lab automation market report can gain segment-specific vendor insights to identify and evaluate key competitors based on an in-depth assessment of their capabilities and success in the marketplace. Detailed profiles of lab automation providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings, and recent developments in the lab automation space. Some of the key competitors covered in the lab automation market are Abbott Laboratories, Agilent Technologies, Perkin Elmer, Inc, Thermo Fisher Scientific, Inc, Siemens Healthcare, Danaher Corporation, Becton, Dickinson and Company, and Transcriptic, Inc.
Key Segments Covered in the Lab Automation Market Report
-
Component Type
-
Devices
-
Biochemistry Devices
-
Molecular Devices
-
Hematology Devices
-
Immunology Devices
-
Microbiology Devices
-
Others
-
-
Software
-
Scheduling Software
-
Momentum Integration Software
-
-
-
Application
-
Life Sciences Research and Development
-
Drug Discovery
-
Diagnostics
-
-
End User
-
Pharmaceutical Companies
-
Hospitals and Diagnostic Centers
-
Educational Institutions
-
Contract Research Organizations (CROs)
-
Research Institutes
-
-
Key Regions
-
North America
-
U.S.
-
Canada
-
-
Latin America
-
Brazil
-
Mexico
-
Rest of Latin America
-
-
Western Europe
-
Germany
-
UK
-
France
-
Spain
-
Italy
-
Nordic
-
Rest of Western Europe
-
-
Eastern Europe
-
Russia
-
Poland
-
Rest of Eastern Europe
-
-
Japan
-
APEJ
-
China
-
India
-
ASEAN
-
Australia & New Zealand
-
Rest of APEJ
-
-
Middle East & Africa
-
South Africa
-
GCC
-
Rest of Middle East & Africa
-
-
Key Market Companies
-
AmerisourceBergen Corporation
-
Baxter International Inc.,
-
Swisslog Holdings AG
-
Care Fusion Corporation
-
Cerner Corporation
-
Kirby Lester LLC.
-
Talyst, LLC.
-
Omnicell Inc.
-
ScriptPro LLC.
Get in touch
Harish Tiwari
Global Head - Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.